Kalari Corp Clinical Trial Reveals Promising Outcomes for Yoga in Diabetes Management

TROY, Mich. - Oct. 11, 2023 - PRLog -- Kalari Corp, a leading organization dedicated to holistic well-being, is thrilled to announce the remarkable results of our recent clinical trial, which explored the impact of yoga on individuals with diabetes. This groundbreaking study provides compelling evidence of the profound positive effects of yoga in diabetes management.

Clinical Trial Overview:

Trial Name: Yoga for Diabetes Management (YDM) Lead Investigator: Dr. Ashish Verma Sponsor: Kalari Corp Location: Troy, Michigan

Key Findings:

Our comprehensive clinical trial involved participants with diabetes who engaged in regular yoga practice. The results were highly encouraging, with a significant number of participants reporting remarkable improvements in various aspects of their health and well-being:

1. Improved Sleep Quality: An impressive 83.33% of participants reported significant enhancements in their sleep quality. Quality sleep is crucial for overall health and is often compromised in individuals with diabetes.
2. Reduced Stress and Anxiety: 66.66% of participants experienced a notable reduction in their stress and anxiety levels. This finding suggests that yoga has a positive impact on mental well-being, a crucial aspect of diabetes management.
3. Enhanced Joint Mobility: A striking 91.66% of participants enjoyed increased joint mobility and a better range of motion. This is particularly beneficial for individuals dealing with diabetes-related complications.
4. Increased Motivation to Stay Active: 91.66% of participants demonstrated a remarkable boost in motivation to engage in physical activity, a crucial component of diabetes management.
5. Surge in Energy Levels: 83.33% of participants reported a surge in energy levels following their yoga sessions. Enhanced energy can contribute to an improved quality of life.
6. Lower Blood Pressure: 62.5% of participants exhibited a significant decrease in their blood pressure levels, highlighting the potential of yoga as an adjunct therapy for hypertension often associated with diabetes.
7. Weight Reduction: An impressive 87.5% of participants saw substantial weight reduction, which is pivotal for diabetes management and overall health.
8. Improved HBA1C Levels: 75% of participants experienced improved HbA1c levels, a critical marker in diabetes management, further emphasizing the therapeutic potential of yoga.

Conclusion:

The outcomes of the Kalari Corp's Yoga for Diabetes Management clinical trial are highly promising and suggest that yoga can play a pivotal role in improving the well-being of individuals with diabetes. These findings encourage us to explore yoga as an integral part of a holistic approach to diabetes care and management.

This research signifies a significant step forward in the quest for innovative and accessible diabetes management strategies. Kalari Corp remains committed to advancing holistic well-being and will continue to explore the intersection of traditional practices, like yoga, with modern healthcare.

For more information please visit our website at https://yogabykalari.com